Longevity

ARA-290

Peptide injectable

ARA-290 is available in a 10mg vial from the CTFD master catalog.

ARA-290 10mg

ARA-290 - 10mg

Peptide injectable

$76/mo

References

  1. ARA-290 - Peptide Center guide
  2. ARA290 Attenuates Apical Periodontitis via SIRT1/NF-κB/IL-1β Pathway ModulationInternational dental journal, 2025
  3. Nonerythropoietic Erythropoietin Mimetic Peptide ARA290 Ameliorates Chronic Stress-Induced Depression-Like Behavior and Inflammation in MiceFrontiers in pharmacology, 2022
  4. Erythropoietin-derived peptide ARA290 mediates brain tissue protection through the β-common receptor in mice with cerebral ischemic strokeCNS neuroscience & therapeutics, 2024
  5. A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular EdemaJournal of clinical medicine, 2020
  6. Mechanistic Approach for Protective Effect of ARA290, a Specific Ligand for the Erythropoietin/CD131 Heteroreceptor, against Cisplatin-Induced Nephrotoxicity, the Involvement of Apoptosis and Inflammation PathwaysInflammation, 2023
  7. Renoprotective capacities of non-erythropoietic EPO derivative, ARA290, following renal ischemia/reperfusion injuryJournal of translational medicine, 2013

Ready to start with ARA-290?

Take our eligibility quiz to see if this treatment is right for you.

Start Intake